Sec Form 13G Filing - Stephen Boyd Wiles filing for Clearside Biomedical, Inc. (CLSD) - 2025-04-01

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Percentage based on 77,143,872 shares of the Issuer's common stock outstanding as of March 24, 2025, as reported in the Issuer's Annual Report on Form 10-K for the year ended December 31, 2024.


SCHEDULE 13G


 
Stephen Boyd Wiles
 
Signature:/s/ Stephen Boyd Wiles
Name/Title:Stephen Boyd Wiles
Date:04/01/2025
primary_doc.xml